Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion
Abigael Cheruiyot, … , Susan Bonner-Weir, Jean E. Schaffer
Abigael Cheruiyot, … , Susan Bonner-Weir, Jean E. Schaffer
Published November 30, 2023
Citation Information: J Clin Invest. 2024;134(3):e173280. https://doi.org/10.1172/JCI173280.
View: Text | PDF
Research Article Endocrinology Metabolism

Sustained hyperglycemia specifically targets translation of mRNAs for insulin secretion

  • Text
  • PDF
Abstract

Pancreatic β cells are specialized for coupling glucose metabolism to insulin peptide production and secretion. Acute glucose exposure robustly and coordinately increases translation of proinsulin and proteins required for secretion of mature insulin peptide. By contrast, chronically elevated glucose levels that occur during diabetes impair β cell insulin secretion and have been shown experimentally to suppress insulin translation. Whether translation of other genes critical for insulin secretion is similarly downregulated by chronic high glucose is unknown. Here, we used high-throughput ribosome profiling and nascent proteomics in MIN6 insulinoma cells to elucidate the genome-wide impact of sustained high glucose on β cell mRNA translation. Before induction of ER stress or suppression of global translation, sustained high glucose suppressed glucose-stimulated insulin secretion and downregulated translation of not only insulin, but also mRNAs related to insulin secretory granule formation, exocytosis, and metabolism-coupled insulin secretion. Translation of these mRNAs was also downregulated in primary rat and human islets following ex vivo incubation with sustained high glucose and in an in vivo model of chronic mild hyperglycemia. Furthermore, translational downregulation decreased cellular abundance of these proteins. Our study uncovered a translational regulatory circuit during β cell glucose toxicity that impairs expression of proteins with critical roles in β cell function.

Authors

Abigael Cheruiyot, Jennifer Hollister-Lock, Brooke Sullivan, Hui Pan, Jonathan M. Dreyfuss, Susan Bonner-Weir, Jean E. Schaffer

×

Figure 3

Sustained high glucose treatment has genome-wide impact on translation.

Options: View larger image (or click on image) Download as PowerPoint
Sustained high glucose treatment has genome-wide impact on translation.
...
MIN6 cells incubated in medium containing 5.5 mM (gray) or 25 mM (red) GLU for 24 hours were analyzed by ribosome profiling. (A) Workflow for RNA sequence analysis of ribosome-protected footprints (RPFs; translatome) and total RNA (transcriptome). (B) RPF read lengths. Boxes indicate 25th to 75th percentiles, line in middle of box is the median, and whiskers go from smallest to largest values. (C) Distribution of reads to coding sequence (CDS; hatched), 5′-UTR (open), and 3′-UTR (filled) for RNAs and RPFs. (D) Triplet periodicity of RPFs near CDS start and stop. (E–G) Volcano plots of –log FDR versus log2 fold change (FC), calculated for 25 mM versus 5.5 mM GLU for RNA (E; dotted line FDR = 0.01), RPF (F; dotted line FDR = 0.1), and translation efficiency (TE = RPF/RNA; G; dotted line FDR = 0.1). (H and I) Representative Reactome gene sets overrepresented at a significance threshold FDR < 0.05 as upregulated (H) and downregulated (I) by 25 versus 5.5 mM glucose. Numbers of regulated genes in pathways indicated by numbers in parentheses. n = 8 independent samples per condition.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts